Supporting Drug Development
As the largest Contract Research Organization (CRO) in Japan, we provide experienced non-clinical, clinical and regulatory consulting solutions. From Preclinical to Clinical Phase I-III and post-approval, our CRO team helps keep your product on the path to market. CMIC provides global support in Japan, USA, China, Australia, and other locations.
Our Edge in CRO Services
The First and Largest CRO in Japan
- Over 25 years ago, CMIC Group was founded as the first CRO in Japan. Now, our 1200+ CRAs and 120+ consultants in Japan and Asia Pacific support global clinical trials in various therapeutic areas.
Non-clinical Support Provides Seamless Precision
- Through our compliance with various regulatory agencies, dedicated consulting team, coordinated analysis between Japan and US and global transfer capabilities, CMIC is able to move your drug candidate from preclinical research to Phase I-III clinical trials with seamless precision.
Support for Every Pharmaceutical Development Process
- Using our deep business experience in a broad range of disease specialties, we provide our clients with support at all stages of pharmaceutical development, from phase I to phase IV clinical studies.
- With over 135 active clinical trial sites in China, Thailand, Hong Kong, Vietnam, Malaysia, Singapore, Australia, New Zealand, Indonesia, Taiwan, South Korea, the Philippines, CMIC Group has the capability to support our client’s clinical trials throughout Asia.